Abvc Biopharma (ABVC) Other Operating Expenses (2010 - 2026)

Abvc Biopharma (ABVC) has reported Other Operating Expenses for 14 consecutive years, with $253041.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses fell 83.9% year-over-year to $253041.0; the trailing twelve-month figure through Jun 2026 stood at $3.6 million (up 71.34% YoY), and the FY2025 full-year result was $4.1 million, up 49.37% from the prior year.
• Other Operating Expenses retreated to $253041.0 in Q2 2026 per ABVC's latest filing, from $787374.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $2.0 million in Q1 2024 and bottomed at -$1.2 million in Q4 2023.
• Historically, Other Operating Expenses has averaged $585091.0 across 5 years, with a median of $322977.0 in 2024.
• The sharpest annual moves came in 2023 and 2026: Other Operating Expenses plunged 164.65% in 2023, then jumped 1514.36% in 2026.
• Over 5 years, Other Operating Expenses stood at $1.9 million in 2022, then slumped by 164.65% to -$1.2 million in 2023, then surged by 129.66% to $363079.0 in 2024, then jumped by 281.79% to $1.4 million in 2025, then sank by 81.75% to $253041.0 in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $253041.0, $787374.0, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.